Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors

Domenicali, M.; Ros, J.; Fernández-Varo, G.; Cejudo-Martin, P.; Crespo, M.; Morales-Ruiz, M.; Briones, A. M.; Campistol, J.-M.; Arroyo, V.; Vila, E.; Rodés, J.; Jiménez, W.
April 2005
Gut;Apr2005, Vol. 54 Issue 4, p522
Academic Journal
Background and aims: Anandamide is an endocannabinoid that evokes hypotension by interaction with peripheral cannabinoid CB1 receptors and with the perivascular transient receptor potential vanilloid type 1 protein (TRPV1). As anandamide has been implicated in the vasodiloted state in advanced cirrhosis, the study investigated whether the mesenteric bed from cirrhotic rots has an altered and selective vasodilator response to anandamide. Methods: We assessed vascular sensitivity to anandamide, mRNA and protein expression of cannabinoid CM receptor and TRPV1 receptor, and the topographical distribution of cannabinoid CM receptors in resistance mesenteric arteries of cirrhotic and control rats. Results: Mesenteric vessels of cirrhotic animals displayed greater sensitivity to anandamide than control vessels. This vasodilator response was reverted by CM or TRPV1 receptor blockade, but not after endothelium denudation or nitric oxide inhibition. Anandamide had no effect on distal femoral arteries. CB1 and TRPVI receptor protein was higher in cirrhotic than in control vessels. Neither CM mRNA nor protein was detected in femoral arteries, immunochemistry showed that CB1 receptors were mainly in the adventitia and in the endothelial monolayer, with higher expression observed in vessels of cirrhotic rats than in controls. Conclusions: These results indicate that anandamide is a selective splanchnic vasodilator in cirrhosis which predominantly acts via interaction with two different types of receptors, CB1 and TRPV1 receptors, which are mainly located in perivascular sensory nerve terminals of the mesenteric resistance arteries of these animals.


Related Articles

  • Cannabinoids. Grotenhermen, Franjo // Current Drug Targets - CNS & Neurological Disorders;Oct2005, Vol. 4 Issue 5, p507 

    Since the discovery of an endogenous cannabinoid system, research into the pharmacology and therapeutic potential of cannabinoids has steadily increased. Two subtypes of G-protein coupled cannabinoid receptors, CB1 and CB2, have been cloned and several putative endogenous ligands...

  • Cannabinoids in Energy Balance and Prospectives in the Therapy of Obesity. Marsicano, G.; Cota, D.; Stalla, G.K.; Pasquali, R.; Pagotto, U.; Lutz, B. // Current Medicinal Chemistry - Central Nervous System Agents;Jun2003, Vol. 3 Issue 2, p81 

    During the past decades, obesity has become a major health problem worldwide. Balance of energy homeostasis is one of the most vital functions exerted by animals, and a very complex network of central and peripheral signaling systems is involved in its regulation. Recently, the cannabinoid...

  • The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis. D'Souza, Deepak Cyril; Perry, Edward; MacDougall, Lisa; Ammerman, Yola; Cooper, Thomas; Yu-te Wu; Braley, Gabriel; Gueorguieva, Ralitza; Krystal, John Harrison // Neuropsychopharmacology;Aug2004, Vol. 29 Issue 8, p1558 

    Recent advances in the understanding of brain cannabinoid receptor function have renewed interest in the association between cannabinoid compounds and psychosis. In a 3-day, double-blind, randomized, and counterbalanced study, the behavioral, cognitive, and endocrine effects of 0, 2.5, and 5 mg...

  • Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats. Economidou, Daina; Mattioli, Laura; Cifani, Carlo; Perfumi, Marina; Massi, Maurizio; Cuomo, Vincenzo; Trabace, Luigia; Ciccocioppo, Roberto // Psychopharmacology;Jan2006, Vol. 183 Issue 4, p394 

    Rationale: It has been suggested that endocannabinoid mechanisms are involved in the control of ethanol consumption. Objectives: The aims of the present study were (1) to evaluate the role of the endocannabinoid system in the control of operant ethanol self-administration and in the...

  • Controlled Oral Δ9-Tetrahydrocannabinol Administration: Detection Rates and Times in Urine by CEDIA®, Syva® EMIT II, Microgenics® DRI and GC-MS.  // Journal of Analytical Toxicology;May/Jun2004, Vol. 28 Issue 4, p283 

    Presents the abstract of the study "Controlled Oral Δ9-Tetrahydrocannabinol Administration: Detection Rates and Times in Urine by CEDIA®, Syva® EMIT II, Microgenics® DRI and GC-MS," by Richard A. Gustafson and colleagues.

  • Endocannabinoid Transporter Inhibitors. Lopez-Rodriguez, M.L.; Viso, A.; Ortega-Gutierrez, S.; Fernaandez-Ruiz, J.; Ramos, J.A. // Current Medicinal Chemistry - Central Nervous System Agents;Jun2002, Vol. 2 Issue 2, p129 

    This review gives an overview of the current knowledge of endocannabinoid transporter, its biochemical characterization, localization and most relevant features including its role in the uptake of both anandamide and 2-arachidonoylglycerol and its interaction with the vanilloid system. Also, a...

  • The inheritance of chemical phenotype in Cannabis sativa L. (IV): cannabinoid-free plants. Meijer, E.; Hammond, K.; Sutton, A. // Euphytica;Jul2009, Vol. 168 Issue 1, p95 

    A genetic factor that blocks the cannabinoid biosynthesis in Cannabis sativa has been investigated. Crosses between cannabinoid-free material and high content, pharmaceutical clones were performed. F1s were uniform and had cannabinoid contents much lower than the mean parental value. Inbred F2...

  • Chamber. G.S.R. // Gramophone;Oct96, Vol. 74 Issue 881, p71 

    Reviews the classical music recordings of string quartets composed by Alberto Hindemith, performed by the Juilliard Quartet and the Kocian Quartet. Titles included; Tonal quality; Integral survey of the Hindemith quartets; Distribution of the quartet output; Comparison of the two recordings.

  • Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease. Mendizabal, Victoria E.; Adler-Graschinsky, Edda // Current Vascular Pharmacology;Oct2003, Vol. 1 Issue 3, p301 

    Although cannabinoids have been recreationally employed for thousands of years, it was not until the discovery of their specific receptors, in the early nineties, that the molecular basis of cannabinoid activity have began to be understood. Growing research in this field has demonstrated not...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics